However, CEA is considered particularly useful in the follow‐up in cases of MTC dedifferentiation, when a rising CEA level is observed, accompanied by a stable or decreasing CT trend [20, 21]. This evidence concerns the gene CEACAM5 and medullary thyroid gland carcinoma.